We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Manganese Transport Protein Vital to Lyme Disease Bacteria

By LabMedica International staff writers
Posted on 26 Feb 2009
Print article
Microbiologists studying the bacterium Borrelia burgdorfei (Bb), the causative agent of Lyme disease, have reported finding a unique manganese transport protein that might prove to be the pathogen's Achilles heel.

To establish infection, Bb must acquire essential nutrients, including transition metals such as manganese, from its mammalian and tick hosts. As no metal transporter had been identified in Bb, investigators from the University of Texas Southwestern Medical Center (Dallas, USA) set out to find one.

The protein they found, BmtA, lacked homology to any known manganese transporter, so the investigators speculated that BmtA might comprise a novel mechanism for manganese acquisition by a bacterial pathogen. To study how BmtA works the investigators generated a number of mutant strains of Bb that lacked the gene that encodes for it.

They reported in the February 13, 2009, online edition of the journal the Proceedings of the [U.S.] National Academy of Sciences (PNAS) that the mutants grew slightly slower than wild-type Bb in vitro. BmtA mutants were sensitive to the chelating actions of EDTA (ethylenediaminetetraacetic acid), suggesting a role for BmtA in metal utilization. Intracellular accumulation of manganese was substantially diminished in the mutants, indicating that the protein was operative in manganese uptake.

BmtA was found to be essential to the infectious life cycle of Bb in ticks and mammals. In addition, the mutants were sensitive to treatment with t-butyl hydroperoxide, implying that BmtA, and thus manganese, was important to Bb for detoxifying reactive oxygen species, including those potentially liberated by immune effector cells during the innate immune response.

"When you try to grow the mutant strain in a mouse, however, it cannot grow,” said senior author Dr. Michael Norgard, professor of microbiology at the University of Texas Southwestern Medical Center. "The fact that the bacterium without this particular manganese transporter cannot grow in a mouse raises important questions about what aspects of physiology and metabolism contribute to the pathogenicity of the organism. I really think that there is also something to the notion that manganese may regulate the expression of other virulence factors. It could be that manganese has more of an indirect effect, but more research is needed to determine what must happen for B. burgdorfei to become virulent.”

"We believe our findings provide a foundation for further defining metal homeostasis in this human pathogen and may lead to new strategies for thwarting Lyme disease,” said Dr. Norgard.

Related Links:

University of Texas Southwestern Medical Center



New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
LGC Clinical Diagnostics